{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:24:19Z","timestamp":1773663859620,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities","award":["2023CDJYGRH-YB04"],"award-info":[{"award-number":["2023CDJYGRH-YB04"]}]},{"name":"Chongqing Medical Research Project of Combination of Science and Medicine","award":["No. 2024MSXM171"],"award-info":[{"award-number":["No. 2024MSXM171"]}]},{"name":"the Natural Science Foundation of Chongqing municipality","award":["CSTB2024NSCQ-MSX021"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX021"]}]},{"name":"the Chongqing University Cancer Hospital Scientific Research Capacity Improvement Project","award":["2023nlts004"],"award-info":[{"award-number":["2023nlts004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02219-0","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:34:33Z","timestamp":1770719673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pretreatment dual-energy CT versus diffusion-weighted imaging for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Ying","family":"Cao","sequence":"first","affiliation":[]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Xueqin","family":"Gong","sequence":"additional","affiliation":[]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[]},{"given":"Huifang","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Lihong","family":"Du","sequence":"additional","affiliation":[]},{"given":"Jinfang","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Xiangfei","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"Ting","family":"Yin","sequence":"additional","affiliation":[]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Jiuquan","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"9","key":"2219_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrclinonc.2016.35","volume":"13","author":"L De Mattos-Arruda","year":"2016","unstructured":"De Mattos-Arruda L, Shen R, Reis-Filho JS, Cort\u00e9s J. Translating neoadjuvant therapy into survival benefits: one size does not fit all. Nat Rev Clin Oncol. 2016;13(9):566\u201379.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2219_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1470-2045(17)30914-2","volume":"19","author":"MGM Derks","year":"2018","unstructured":"Derks MGM, van de Velde CJH. Neoadjuvant chemotherapy in breast cancer: more than just downsizing. Lancet Oncol. 2018;19(1):2\u20133.","journal-title":"Lancet Oncol"},{"issue":"9938","key":"2219_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164\u201372.","journal-title":"Lancet"},{"key":"2219_CR4","doi-asserted-by":"crossref","unstructured":"Reig B, Heacock L, Lewin A, Cho N, Moy L. Role of MRI to assess response to neoadjuvant therapy for breast cancer. J Magn Reson Imaging. 2020;52(6).","DOI":"10.1002\/jmri.27145"},{"issue":"11","key":"2219_CR5","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","volume":"14","author":"MB Mainiero","year":"2017","unstructured":"Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, et al. ACR appropriateness Criteria\u00ae breast cancer screening. J Am Coll Radiol. 2017;14(11):S383\u201390.","journal-title":"J Am Coll Radiol"},{"issue":"3","key":"2219_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1148\/radiol.2018180273","volume":"289","author":"SC Partridge","year":"2018","unstructured":"Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, et al. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology. 2018;289(3):618\u201327.","journal-title":"Radiology"},{"issue":"3","key":"2219_CR7","first-page":"520","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L, Breast MRI. State Art Radiol. 2019;292(3):520\u201336.","journal-title":"State Art Radiol"},{"issue":"1","key":"2219_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12967-021-02886-3","volume":"19","author":"S Suo","year":"2021","unstructured":"Suo S, Yin Y, Geng X, Zhang D, Hua J, Cheng F, et al. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models. J Transl Med. 2021;19(1):236.","journal-title":"J Transl Med"},{"issue":"1","key":"2219_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12880-021-00688-z","volume":"21","author":"N Lu","year":"2021","unstructured":"Lu N, Dong J, Fang X, Wang L, Jia W, Zhou Q, et al. Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI. BMC Med Imaging. 2021;21(1):155.","journal-title":"BMC Med Imaging"},{"issue":"2","key":"2219_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1148\/radiol.2018180544","volume":"289","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zheng C, Yang Z, Cheng Z, Deng H, Chen M, et al. Axillary Sentinel lymph nodes in breast cancer: quantitative evaluation at Dual-Energy CT. Radiology. 2018;289(2):337\u201346.","journal-title":"Radiology"},{"issue":"4","key":"2219_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00330-013-3087-4","volume":"24","author":"D Simons","year":"2014","unstructured":"Simons D, Kachelriess M, Schlemmer HP. Recent developments of dual-energy CT in oncology. Eur Radiol. 2014;24(4):930\u20139.","journal-title":"Eur Radiol"},{"issue":"1","key":"2219_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40644-020-00370-7","volume":"21","author":"X Wang","year":"2021","unstructured":"Wang X, Liu D, Zeng X, Jiang S, Li L, Yu T, et al. Dual-energy CT quantitative parameters for evaluating immunohistochemical biomarkers of invasive breast cancer. Cancer Imaging. 2021;21(1):4.","journal-title":"Cancer Imaging"},{"issue":"5","key":"2219_CR13","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.21037\/qims-20-825","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Liu D, Zeng X, Jiang S, Li L, Yu T, et al. Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer. Quant Imaging Med Surg. 2021;11(5):1946\u201357.","journal-title":"Quant Imaging Med Surg"},{"issue":"9","key":"2219_CR14","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1007\/s00330-025-11508-1","volume":"35","author":"Y Lin","year":"2025","unstructured":"Lin Y, Lan Y, Zheng Y, Ma M. Dual-energy CT for evaluating the tumor regression grade of gastric cancer after neoadjuvant chemotherapy. Eur Radiol. 2025;35(9):5748\u201359.","journal-title":"Eur Radiol"},{"key":"2219_CR15","doi-asserted-by":"crossref","unstructured":"Lin X, Xu S, Wang Y, Ma F, Qu J, Wu Y, et al. Sequential dual-energy CT for longitudinal assessment of pathologic response to neoadjuvant immuno-chemotherapy in locally advanced gastric cancer. Eur Radiol. 2025.","DOI":"10.1007\/s00330-025-11601-5"},{"issue":"1","key":"2219_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13244-024-01752-2","volume":"15","author":"H Xia","year":"2024","unstructured":"Xia H, Chen Y, Cao A, Wang Y, Huang X, Zhang S, et al. Differentiating between benign and malignant breast lesions using dual-energy CT-based model: development and validation. Insights Imaging. 2024;15(1):173.","journal-title":"Insights Imaging"},{"issue":"5","key":"2219_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast Cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2219_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41598-022-27221-8","volume":"13","author":"A Zegad\u0142o","year":"2023","unstructured":"Zegad\u0142o A, R\u00f3\u017cyk A, \u017babicka M, Wi\u0119sik-Szewczyk E, Maliborski A. Dual-energy computed tomography as a lower radiation dose alternative to perfusion computed tomography in tumor viability assessment. Sci Rep. 2023;13(1):120.","journal-title":"Sci Rep"},{"issue":"7","key":"2219_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3348\/kjr.2019.0711","volume":"21","author":"C Kim","year":"2020","unstructured":"Kim C, Kim W, Park SJ, Lee YH, Hwang SH, Yong HS, et al. Application of Dual-Energy spectral computed tomography to thoracic oncology imaging. Korean J Radiol. 2020;21(7):838\u201350.","journal-title":"Korean J Radiol"},{"issue":"20","key":"2219_CR20","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1111\/1759-7714.14105","volume":"12","author":"B Zhu","year":"2021","unstructured":"Zhu B, Zheng S, Jiang T, Hu B. Evaluation of dual-energy and perfusion CT parameters for diagnosing solitary pulmonary nodules. Thorac Cancer. 2021;12(20):2691\u20137.","journal-title":"Thorac Cancer"},{"issue":"10","key":"2219_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer. 2004;4(10):806\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2219_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.2214\/AJR.19.22688","volume":"215","author":"Q Li","year":"2020","unstructured":"Li Q, Li X, Li XY, Huo JW, Lv FJ, Luo TY. Spectral CT in lung cancer: usefulness of iodine concentration for evaluation of tumor angiogenesis and prognosis. AJR Am J Roentgenol. 2020;215(3):595\u2013602.","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"2219_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3748\/wjg.v23.i9.1666","volume":"23","author":"XH Chen","year":"2017","unstructured":"Chen XH, Ren K, Liang P, Chai YR, Chen KS, Gao JB. Spectral computed tomography in advanced gastric cancer: can iodine concentration non-invasively assess angiogenesis? World J Gastroenterol. 2017;23(9):1666\u201375.","journal-title":"World J Gastroenterol"},{"key":"2219_CR24","doi-asserted-by":"publisher","first-page":"967655","DOI":"10.3389\/fonc.2022.967655","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Wang H, Chen F, Gao L, Zhou Y, Zhou Z, et al. Detection of axillary lymph node metastasis in breast cancer using dual-layer spectral computed tomography. Front Oncol. 2022;12:967655.","journal-title":"Front Oncol"},{"issue":"9","key":"2219_CR25","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1007\/s00330-024-10642-6","volume":"34","author":"J Li","year":"2024","unstructured":"Li J, Xu S, Wang Y, Ma F, Chen X, Qu J. Spectral CT vs. diffusion-weighted imaging for the quantitative prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer. Eur Radiol. 2024;34(9):6193\u2013204.","journal-title":"Eur Radiol"},{"issue":"1","key":"2219_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40644-022-00501-2","volume":"22","author":"A Surov","year":"2022","unstructured":"Surov A, Pech M, Meyer HJ, Bitencourt AGV, Fujimoto H, Baxter GC, et al. Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study. Cancer Imaging. 2022;22(1):68.","journal-title":"Cancer Imaging"},{"issue":"6","key":"2219_CR27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1007\/s00330-010-2020-3","volume":"21","author":"A Fangberget","year":"2011","unstructured":"Fangberget A, Nilsen LB, Hole KH, Holmen MM, Engebraaten O, Naume B, et al. Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol. 2011;21(6):1188\u201399.","journal-title":"Eur Radiol"},{"issue":"9","key":"2219_CR28","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00330-013-2850-x","volume":"23","author":"R Richard","year":"2013","unstructured":"Richard R, Thomassin I, Chapellier M, Scemama A, de Cremoux P, Varna M, et al. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol. 2013;23(9):2420\u201331.","journal-title":"Eur Radiol"},{"issue":"22","key":"2219_CR29","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-14-2945","volume":"75","author":"JA Weis","year":"2015","unstructured":"Weis JA, Miga MI, Arlinghaus LR, Li X, Abramson V, Chakravarthy AB, et al. Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled Reaction-Diffusion model. Cancer Res. 2015;75(22):4697\u2013707.","journal-title":"Cancer Res"},{"issue":"6","key":"2219_CR30","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.18632\/oncotarget.23195","volume":"9","author":"W Chu","year":"2018","unstructured":"Chu W, Jin W, Liu D, Wang J, Geng C, Chen L, et al. Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis. Oncotarget. 2018;9(6):7088\u2013100.","journal-title":"Oncotarget"},{"issue":"1","key":"2219_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1148\/radiol.09090068","volume":"254","author":"DT Boll","year":"2010","unstructured":"Boll DT, Patil NA, Paulson EK, Merkle EM, Nelson RC, Schindera ST, et al. Focal cystic high-attenuation lesions: characterization in renal Phantom by using photon-counting spectral CT\u2013improved differentiation of lesion composition. Radiology. 2010;254(1):270\u20136.","journal-title":"Radiology"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02219-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:41:02Z","timestamp":1773661262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02219-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Chongqing University Cancer Hospital, Chongqing, China (approval No. CZLS20200215-A). Written informed consent was obtained from all individual participants before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}